doi: 10.3390/ijms23084181 218 PhuaJ.WengL.LingL.EgiM.LimC.-M.DivatiaJ
Youre still early in the titration process Semaglutide is started at a low dose and increased slowly over several weeks to help your body adjust
Ozempic and Mounjaro, however, are FDA-approved to manage diabetes, but due to their significant effectiveness in weight loss, they are commonly prescribed off-label to manage obesity
[10] [11] Phase 2 trial data published in the New England Journal of Medicine in 2023 (Jastreboff et al.) demonstrated substantial effects on body weight and metabolic parameters, though the full benefitrisk profile is still being established in ongoing Phase 3 trials
Enter this value into the calculator
Compounded or branded, success depends on adherence, lifestyle integration, and individual metabolic factors